Cyclophosphamide (CTX) Clinical Trials
7 recruitingDrug
Phase 14Phase 23
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors
Advanced Solid Tumors
Shanghai NK Cell Technology Co., LTD76 enrolled1 locationNCT06773091
Recruiting
Rapid dFLC Response Predict CHR in AL Amyloidosis
Systemic AL Amyloidosis
Peking University People's Hospital50 enrolled8 locationsNCT06627309
Recruiting
Phase 2
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
Metastatic Prostate Cancer
Sun Yat-sen University104 enrolled1 locationNCT06854250
Recruiting
Phase 2
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Acute Myeloid Leukemia, Relapsed, Adult
University of Illinois at Chicago38 enrolled1 locationNCT06802315
Recruiting
Phase 1Phase 2
R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China108 enrolled1 locationNCT06594640
Recruiting
Phase 1
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
Hematologic Disease
He Huang29 enrolled1 locationNCT06809712
Recruiting
Phase 1
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
Hematologic Diseases
He Huang29 enrolled1 locationNCT06809699